Dr. Matthew Lewis is the Vice President of Metabolomics & Lipidomics at Bruker Daltonics and Head of Markets at TOFWERK. For the past 25 years, Lewis has pursued his interests in better understanding biochemical processes and improving the analytical tools and techniques used to measure them. At Imperial College London, he served as the chief operating officer of the UK's National Phenome Centre and head of the academic section of Bioanalytical Chemistry in the Faculty of Medicine. Here, he worked to advance the understanding of human disease phenotypes using advanced bioanalytical and data analysis techniques for metabolic profiling at a previously unprecedented scale. Lewis transitioned to industry in 2022 to more directly further the development of research-enabling solutions through his role at Bruker Daltonics. He takes great pleasure in extensive engagement in interdisciplinary team science and large-scale scientific collaborations, supporting advancements in the fields of metabolomics and lipidomics.